Article
Brain metabolic resilience conferred by the APOE3 Christchurch variant in autosomal dominant Alzheimer’s disease and across the adult lifespan
2026-08-14
Abstract excerpt
<title>Abstract</title> <p> The <italic>APOE3</italic> Christchurch ( <italic>APOE3</italic> <sup> <italic>Ch</italic> </sup> ) is a rare genetic variant associated with marked protection against autosomal-dominant Alzheimer’s disease (ADAD) due to the <italic>PSEN1</italic> <sup> <italic>E280A</italic> </sup> variant, by delaying the onset of clinical symptoms. In this study, we investigate age-rela...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a8acc6f2-b965-552e-ad0a-ecd079b1abb8
- DOI
- 10.21203/rs.3.rs-10145165/v1
